Blar i Publikasjoner fra Cristin - St. Olavs hospital på tidsskrift "Blood Advances"
Viser treff 1-1 av 1
-
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
(Peer reviewed; Journal article, 2020)Survival of patients with high-risk diffuse large B-cell lymphoma (DLBCL) is suboptimal, and the risk of central nervous system (CNS) progression is relatively high. We conducted a phase 2 trial in 139 patients aged 18 to ...